Aerpio Pharmaceuticals, Inc. - ARPO

SEC FilingsOur ARPO Tweets

About Gravity Analytica

Recent News

    Recent Filings

    • 02.05.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
    • 02.04.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
    • 01.31.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition
    • 01.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
    • 01.21.2025 - PREM14A Preliminary proxy statements relating to merger or acquisition
    • 12.23.2024 - 3 Initial statement of beneficial ownership of securities
    • 12.23.2024 - 4 Statement of changes in beneficial ownership of securities
    • 12.20.2024 - EX-99.1 EX-99.1
    • 12.20.2024 - 8-K Current report
    • 11.06.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]